206 related articles for article (PubMed ID: 6191567)
21. Renal effects of angiotensin converting enzyme inhibitors in hypertension.
Bauer JH; Reams GP
Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581
[TBL] [Abstract][Full Text] [Related]
22. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
Novikova LS; Arabidze GG
Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004
[No Abstract] [Full Text] [Related]
23. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats.
Kaukinen S; Kataja J; Ylitalo P
Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406
[TBL] [Abstract][Full Text] [Related]
24. Renal response to angiotensin-converting enzyme inhibition.
Hollenberg NK
Am J Cardiol; 1982 Apr; 49(6):1425-9. PubMed ID: 6176107
[TBL] [Abstract][Full Text] [Related]
25. The renin-angiotensin system and body function.
Reid IA
Arch Intern Med; 1985 Aug; 145(8):1475-9. PubMed ID: 2992406
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Cohn JN; Levine TB
Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of renin in the hypertensive patient.
Brunner HR; Gavras H
JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
[No Abstract] [Full Text] [Related]
28. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
Case DB; Wallace JM; Laragh JH
Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
[No Abstract] [Full Text] [Related]
29. [Inhibition of the renin-angiotensin system in treating arterial hypertension].
Fagard R; Leuven KU; Staessen J; Amery A
Ter Arkh; 1982; 54(11):68-70. PubMed ID: 6186041
[No Abstract] [Full Text] [Related]
30. Why use angiotensin converting enzyme inhibitors to lower blood pressure?
MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S92-7. PubMed ID: 2412021
[TBL] [Abstract][Full Text] [Related]
31. Editorial: Mechanisms in hypertension.
Lancet; 1975 Sep; 2(7932):445. PubMed ID: 51247
[No Abstract] [Full Text] [Related]
32. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
Pagny JY; Thibonnier M; Corvol P; Menard J
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
[TBL] [Abstract][Full Text] [Related]
33. Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition.
Brunner HR; Waeber B; Nussberger J
Kidney Int Suppl; 1988 Oct; 26():S80-5. PubMed ID: 2904507
[No Abstract] [Full Text] [Related]
34. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ
J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274
[No Abstract] [Full Text] [Related]
35. [The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey].
Molinatti GM; Limone P
Minerva Med; 1981 Mar; 72(12):715-32. PubMed ID: 6164019
[TBL] [Abstract][Full Text] [Related]
36. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
[TBL] [Abstract][Full Text] [Related]
37. Renin--angiotensin antagonists and the regulation of blood pressure.
Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
[TBL] [Abstract][Full Text] [Related]
38. Failure of chronic administration of the angiotensin I-converting enzyme inhibitor, Teprotide (SQ 20881), to affect the ultrastructure of the adrenal cortex and the aldosterone secretion in the rat.
Weaver J; Nickerson PA; Molteni A; Solliday N; Albertson D
Lab Invest; 1981 Dec; 45(6):527-33. PubMed ID: 6172661
[TBL] [Abstract][Full Text] [Related]
39. Combined intrarenal renin-angiotensin blockade alters renal function and this is reversed by angiotensin II.
Siragy HM; Howell NL; Peach MJ; Carey RM
J Hypertens Suppl; 1989 Dec; 7(6):S174-5. PubMed ID: 2698923
[TBL] [Abstract][Full Text] [Related]
40. Modern concepts in the drug treatment of arterial hypertension.
van Zwieten PA
Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):412-9. PubMed ID: 6108920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
